Skip to search.
 FTSE 100 Down 0.43%

Alkermes plc (ALKS)

-NasdaqGS
69.14 Down 2.08(2.92%) 16:04 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:71.22
Open:70.90
Bid:69.47 x 200
Ask:69.52 x 400
1y Target Est:71.90
Beta:1.31
Next Earnings Date:N/A
Day's Range:69.05 - 71.00
52wk Range:38.49 - 75.17
Volume:470,818
Avg Vol (3m):1,385,950
Market Cap:10.24b
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 2.92%10.24b
ABTDown 1.23%70.70b
LLYDown 1.93%73.43b
GSKDown 1.05%113.30b

Key Statistics

Forward P/E (1 yr):534.38
P/S (ttm):17.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Mar-15) :-0.03
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-31.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback